Real World Evidence & Advanced Data Strategy

This marcus evans conference will facilitate dialogue and exchanges among stakeholders about the real application, impact and opportunity in incorporating RWE in all stage of the drug and product strategy, exploring unmet needs, precision medicine and new opportunities to meet patient’s needs.

Integrating the complexity of information about patients in the medical product development is one of the challenges that the pharmaceutical industry needs to take. The increase in the generation and use of Real World Evidence and Big Data in health product provides a great opportunity for both pharma and patients to determine more effective treatments and evaluation of therapeutics. Nevertheless, this opportunity comes along with important transformation and changes for the pharma and healthcare industry to open silos, develop a robust Data strategy across the product value chain; assess and analyse data from various sources and volume; translate RWE into actionable insights and combine efficiently the use of the most performing technologies.